Author details

Full Name

Jeremy N Rich

Affiliation

UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

ORCID

Career Start Year

1992

Papers

323

H Index

106

Expertise

CM4AI Collaborator

Nevan J Krogan (CM4AI)

PMID	Paper Title	Journal Title	Published Year
38087889	Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation.	Adv Sci (Weinh)	2024
38087889	Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation.	Adv Sci (Weinh)	2024
36394953	Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.	J Clin Invest	2023
35608632	Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.	Neuro Oncol	2023
35980802	Growth factor receptor signaling induces mitophagy through epitranscriptomic regulation.	Autophagy	2023
36394953	Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.	J Clin Invest	2023
37945900	Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.	Nat Genet	2023
37980347	LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2'-O-methylation.	Nat Commun	2023
37979586	EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.	Mol Cell	2023
37623431	Reply to "Targeting cholesterol homeostasis through inhibiting: An Achilles' heel for glioblastoma?"	Neuro Oncol	2023
36521011	Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.	Neuro Oncol	2023
37280108	Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.	Stem Cells	2023
37085539	3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.	Nat Commun	2023
36649564	Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.	Cancer Discov	2023
36581779	ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.	J Neurooncol	2023
37398280	Human plasma-like medium facilitates metabolic tracing and enables upregulation of immune signaling pathways in glioblastoma explants.	bioRxiv	2023
37198486	Lysine catabolism reprograms tumour immunity through histone crotonylation.	Nature	2023
37326042	Watching the clock in glioblastoma.	Neuro Oncol	2023
37439870	Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages.	Clin Cancer Res	2023
36934350	Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake.	Neuro Oncol	2023
36795488	Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting.	JCI Insight	2023
36732025	WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.	Genes Dev	2023
36849558	A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.	Nat Cell Biol	2023
36595671	Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle.	Proc Natl Acad Sci U S A	2023
37623431	Reply to "Targeting cholesterol homeostasis through inhibiting: An Achilles' heel for glioblastoma?"	Neuro Oncol	2023
37945900	Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.	Nat Genet	2023
37980347	LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2'-O-methylation.	Nat Commun	2023
37979586	EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.	Mol Cell	2023
35608632	Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.	Neuro Oncol	2023
37326042	Watching the clock in glioblastoma.	Neuro Oncol	2023
37085539	3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.	Nat Commun	2023
37280108	Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.	Stem Cells	2023
37439870	Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages.	Clin Cancer Res	2023
37398280	Human plasma-like medium facilitates metabolic tracing and enables upregulation of immune signaling pathways in glioblastoma explants.	bioRxiv	2023
37198486	Lysine catabolism reprograms tumour immunity through histone crotonylation.	Nature	2023
36521011	Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.	Neuro Oncol	2023
36849558	A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.	Nat Cell Biol	2023
36649564	Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.	Cancer Discov	2023
36581779	ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.	J Neurooncol	2023
36934350	Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake.	Neuro Oncol	2023
36732025	WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.	Genes Dev	2023
36795488	Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting.	JCI Insight	2023
36595671	Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle.	Proc Natl Acad Sci U S A	2023
35980802	Growth factor receptor signaling induces mitophagy through epitranscriptomic regulation.	Autophagy	2023
34615656	Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.	Cancer Discov	2022
35659339	PDGF signaling inhibits mitophagy in glioblastoma stem cells through N<sup>6</sup>-methyladenosine.	Dev Cell	2022
35841593	Î²2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages.	Cancer Res	2022
35710946	Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.	Nat Rev Cancer	2022
35393416	CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity.	Nat Commun	2022
36097162	SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus.	Nat Commun	2022

1 - 50 of 646

David Pauck

German Cancer Research Center (DKFZ)

Career Start Year 2017

Number of shared co-authors 16

Olivia Singh

Princess Margaret Cancer Centre

Career Start Year 2016

Number of shared co-authors 7

Jason K Sa

Korea University, College of Medicine

Career Start Year 2015

Number of shared co-authors 21

Chirayu Chokshi

McMaster University

Career Start Year 2015

Number of shared co-authors 10

Nazanin Tatari

McMaster University

Career Start Year 2015

Number of shared co-authors 13

Veronique Frattini

Institute for Cancer Genetics, Columbia University Medical Center

Career Start Year 2011

Number of shared co-authors 8

Jin-Ku Lee

Seoul National University, College of Medicine

Career Start Year 2010

Number of shared co-authors 9

Maxim Sidorov

California Pacific Medical Center Research Institute

Career Start Year 2009

Number of shared co-authors 3

Chitra Venugopal

McMaster Stem Cell and Cancer Research Institute

Career Start Year 2006

Number of shared co-authors 21

Catherine P Langford

University of Alabama at Birmingham

Career Start Year 2005

Number of shared co-authors 2

Verlene Henry

The MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 2

Adam M Sonabend

Northwestern University

Career Start Year 2005

Number of shared co-authors 7

Roel G W Verhaak

Yale School of Medicine

Career Start Year 2004

Number of shared co-authors 47

Massimo Squatrito

Seve Ballesteros Foundation Brain Tumor group

Career Start Year 2002

Number of shared co-authors 11

Brent A Orr

St. Jude Children's Research Hospital

Career Start Year 2000

Number of shared co-authors 58

Agnieszka Bronisz

Mossakowski Medical Research Institute, Polish Academy of Sciences

Career Start Year 1999

Number of shared co-authors 3

Yuhui Yang

Xuanwu Hospital, Capital Medical University

Career Start Year 1999

Number of shared co-authors 6

Ghazaleh Tabatabai

University Hospital Tubingen, Eberhard-Karls-University Tubingen

Career Start Year 1998

Number of shared co-authors 21

Shwetal Mehta

Barrow Neurological Institute, St. Joseph's Hospital and Medical Center

Career Start Year 1998

Number of shared co-authors 4

Shi-Yuan Cheng

Northwestern University Feinberg School of Medicine

Career Start Year 1996

Number of shared co-authors 14

Christopher Ryan Miller

University of Illinois at Urbana-Champaign

Career Start Year 1996

Number of shared co-authors 34

Erik P Sulman

NYU Grossman School of Medicine

Career Start Year 1995

Number of shared co-authors 32

Bj??rn Scheffler

German Cancer Research Center (DKFZ)

Career Start Year 1992

Number of shared co-authors 11

Donald M O'Rourke

Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

Career Start Year 1991

Number of shared co-authors 9

Candelaria Gomez-Manzano

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1990

Number of shared co-authors 12

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Career Start Year 1990

Number of shared co-authors 13

Howard Colman

Huntsman Cancer Institute, University of Utah

Career Start Year 1990

Number of shared co-authors 53

Amy B Heimberger

Northwestern University Feinberg School of Medicine

Career Start Year 1988

Number of shared co-authors 31

Frederick F Lang

The University of Texas M.D. Anderson Cancer Center